Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BIOX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
March 31, 2026 63.80M
December 31, 2025 67.12M
September 30, 2025 249.38M
June 30, 2025 256.16M
March 31, 2025 299.17M
December 31, 2024 300.27M
September 30, 2024 300.19M
June 30, 2024 305.76M
March 31, 2024 304.07M
December 31, 2023 291.26M
September 30, 2023 289.68M
June 30, 2023 289.31M
March 31, 2023 291.81M
December 31, 2022 263.36M
September 30, 2022 271.23M
June 30, 2022 127.18M
March 31, 2022 87.60M
Date Value
December 31, 2021 83.45M
September 30, 2021 73.05M
June 30, 2021 67.04M
March 31, 2021 60.32M
December 31, 2020 60.56M
September 30, 2020 45.08M
June 30, 2020 45.48M
March 31, 2020 44.28M
December 31, 2019 46.74M
September 30, 2019 29.39M
June 30, 2019 47.30M
March 31, 2019 37.13M
January 31, 2019 118.23M
October 31, 2018 118.00M
July 31, 2018 117.69M
April 30, 2018 117.40M
January 31, 2018 0.0122M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Albemarle Corp. 10.28B
American Vanguard Corp. 181.39M
Core Molding Technologies, Inc. --
FMC Corp. 1.637B
Basanite, Inc. -11.45M

Shareholders Equity (Quarterly) Related Metrics